Sigma-Aldrich — FY2012 Earnings Presentation
28 slides from Sigma-Aldrich's earnings presentation, Feb 14, 2013
Slide 1: Sigma-Aldrich Corporation February 2013 Investor Information
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Sigma-Aldrich Corporation February 2013 Investor Information
Slide 2: Cautionary Statements
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 2 Cautionary Statements • The earnings call and this presentation contain “forward-looking statements” regarding future sales, earnings, return on equity, cost savings, process improvements, free cash flow, share repurchases, capital expenditures, a
Slide 3: Sigma-Aldrich Overview: Delivering Value Through A Diversified Portfolio
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Sigma-Aldrich Overview 3 Delivering Value Through A Diversified Portfolio No customer comprises more than 2% of sales, no product more than 1% GLOBALLY BALANCED 43% Total Americas 37% Europe, Middle East, Africa 20% Asia Pacific DIVERSE END-MARKETS
Slide 4: Fourth Quarter 2012 Financial Results
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. (1) See Slide 22 for Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow. (2) Special items include one-time extraordinary tax charges and restructuring charges. 4 Fourth Quarter 2012 Financial Results ($ in millions, excep
Slide 5: Full Year 2012 Financial Results
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 5 Full Year 2012 Financial Results ($ in millions, except per share amounts) YEAR-OVER-YEAR 2012 As Reported Excluding Currency and Acquisition Impacts Sales $ 2,623 5% 3% 2012 As Reported Excluding Special Items (2) Operating Income $ 659 2%
Slide 6: 2012 Sales Growth Reconciliation
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 6 2012 Sales Growth Reconciliation 2012 Overall Organic Sales Growth of 3% SAFC Q4 2012 5 % 5 % (1)% (3)% 17 % 15 % 21 % 17 % Research Q4 2012 2 % 2 % (2)% (4)% 1 % 1 % 1% (1)% Total Customer Sales Q4 2012 3 % 3 % (2)% (3)% 6 % 5 % 7 % 5 % Sales Gro
Slide 7: 2012 Sales Performance Highlight vs. PY
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 7 2012 Sales Performance Highlight vs. PY Q1 Q2 Q3 Q4 Full Year Business Unit: > 5% Research: Analytical 0-5% Biology < 0% Chemistry Lab Essentials/Labware SAFC: Hitech Bioscience Custom Pharma Supply Solutions Geographic: United States & Canada EME
Slide 8: Margin Analysis
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 8 Margin Analysis Percentage of Sales Q4 2012 Adjusted Operating Income Margin – 2012 (1) 25.2% 25.7% Less Impact of: Currency 1.2% 0.6% Incremental Amortization From Recent Acquisitions 0.4% 0.5% Adjusted Operating Income Margin – 2012 (1) before C
Slide 9: 2012 Highlights
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. • Record sales, profits and free cash flow • Significant investments and actions for growth and process improvement • Expanded footprint in emerging markets • Investments in manufacturing process improvements • Additional capacity for SAFC Life Scie
Slide 10: History of the Company
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. History of the Company 38 Consecutive Years of Increasing EPS and Annual Dividends 10
Slide 11: We Have Been Successful in Driving Our Products into a Variety of Customer Classes
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. We Have Been Successful in Driving Our Products into a Variety of Customer Classes 11 Academic & Government Researchers Pharma & Biotech Discovery R&D Contract Research Organizations Dealers Clinical Laboratories Testing Labs Environmental Labs Indu
Slide 12: Enhancing Focus through a Customer-Centric Lens
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. APPLIED COMMERCIAL RESEARCH Enhancing Focus through a Customer-Centric Lens 12 Academic & Government Researchers Pharma & Biotech Discovery R&D Contract Research Organizations Dealers Clinical Laboratories Testing Labs Environmental Labs Industrial
Slide 13: Creation of Customer-Focused Business Units
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Creation of Customer-Focused Business Units 13 Life Science Products Hitech Electronics Life Science Services Diagnostics /Testing Industrial Applications Academic & Government Research Pharma Dealers PREVIOUS Product-focused Organization RESEARCH A
Slide 14: Realigning Into Three Customer-Focused Business Units
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 14 Description Reagents and consumables to life sciences and non-profit research organizations Raw materials and solutions for testing in clinical and industrial applications Critical raw materials, APIs and services for commercial products Customer
Slide 15: Research Business Unit
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. RESEARCH Business Unit 15 Academic & Government Pharma & Biotech Discovery Dealers INITIATIVES CUSTOMER FOCUS • Continue to broaden product portfolio • Broaden/deepen our sales channels - eCommerce - Direct sales - Dealers • Work closer with major c
Slide 16: Realigning Into Three Customer-Focused Business Units
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 16 Description Reagents and consumables to life sciences and non-profit research organizations Raw materials and solutions for testing in clinical and industrial applications Critical raw materials, APIs and services for commercial products Customer
Slide 17: SAFC Commercial Business Unit
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. SAFC Life Science Products Hitech Electronics SAFC Life Science Services SAFC COMMERCIAL Business Unit 17 INITIATIVES CUSTOMER FOCUS • SAFC Top-100 Customer Strategy • Strengthen our leading position in cell culture media • Leverage our High Potency
Slide 18: Realigning Into Three Customer-Focused Business Units
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 18 Description Reagents and consumables to life sciences and non-profit research organizations Raw materials and solutions for testing in clinical and industrial applications Critical raw materials, APIs and services for commercial products Customer
Slide 19: Applied Business Unit: Moving Up the Value Chain
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Clinical Diagnostics Environmental Labs Industrial Applications APPLIED Business Unit 19 MOVING UP THE VALUE CHAIN CUSTOMER FOCUS COMPONENTS • Antibodies • Lab Essentials • Standards • Sample Prep • Oligos • Enzymes • LC/GC Columns • Solvents • Buff
Slide 20: Overall 2012 Organic Growth Driven by Applied and SAFC Commercial
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 20 Overall 2012 Organic Growth was Driven by the Applied and SAFC Commercial Business Units Customer-Focused Business Units Organic Sales Growth (unaudited) Business Unit: Research 3% 1% Applied 6% 4% SAFC Commercial 11% 5% Total 5% 3% Research 57%
Slide 21: 2013 Guidance
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 21 2013 Guidance Organic Sales Growth 2013 full-year adjusted EPS expected to be $4.10 - 4.20 1st Half 2nd Half Full Year Research Low-single digit Low-single digit Low-to-mid single digit Applied Mid-single digit Mid-single digit SAFC Commercial Mi
Slide 22: Key Considerations for 2013
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Key Considerations for 2013 22 Positioning for continued growth in 2013 • Macro-economic environment • Pharma consolidation / site closures • Increased presence in Applied & Industrial Markets • SAFC Growth • Emerging Market Growth • Capital deploym
Slide 23: Proven Formula for Value Creation
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 22.4 22.5 22.9 23.2 24.3 25.8 25.1 2006 2012 1 ,7 9 8 2 ,0 3 9 2 ,2 0 1 2 ,1 4 8 2 ,2 7 1 2 ,5 0 5 2 ,6 2 3 2006 2012 Proven Formula for Value Creation +7% CAGR +270bps +260bps 23 17.5 17.9 18.7 19.8 22.4 23.2 20.1 2006 2012 SALES GROWTH STRONG ROIC
Slide 24: Questions?
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. QUESTIONS? 24
Slide 25: Appendix: Reconciliation of GAAP to Non-GAAP Financial Measures
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Appendix •Reconciliation of GAAP to Non-GAAP Financial Measures
Slide 26: Reconciliation of Reported Net Income and Diluted EPS to Adjusted
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. 2012 2011 2012 2011 Reported net income 116$ 108$ 0.96$ 0.89$ Extraordinary tax charge — 2 — 0.02 Adjusted net income 116$ 110$ 0.96$ 0.91$ 2012 2011 2012 2011 Reported net income 460$ 457$ 3.77$ 3.72$ Acquisition transaction costs 4 — 0.03 — Restru
Slide 27: Reconciliation of Reported Operating Income to Adjusted Operating Income
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Reconciliation of Reported Operating Income to Adjusted Operating Income (Unaudited) 27 2012 2011 2012 2011 Reported operating income 164$ 160$ 659$ 647$ Acquisition transaction costs — — 5 — Restructuring costs 1 — 9 8 Adjusted operating income 165
Slide 28: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
© 2013 Sigma-Aldrich Co. LLC. All rights reserved. Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow (Unaudited) 28 2012 2011 Net cash provided by operating activities 188$ 122$ Less: Capital expenditures (25) (31) Free cash flow 163$ 91$ 2012 2011 Net cash provided by op